{
    "CASP1": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"CASP1\",",
            "  \"brief_summary\": \"Caspase 1, also known as CASP1, is a protease enzyme that plays a central role in the inflammation pathway and the innate immune response. CASP1 is involved in the processing of pro-inflammatory cytokines such as interleukin-1 beta (IL-1\u03b2) and interleukin-18 (IL-18). The enzyme is part of the inflammasome, which is a complex of proteins that serves as a platform for the activation of inflammatory responses upon cellular stress, infection, or other danger signals. CASP1 can also induce pyroptosis, a form of programmed cell death associated with inflammation.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 3,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 7,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 8",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided for the statements are a rough estimate based on general knowledge of the gene's function and current research. These scores may vary depending on the latest scientific evidence and are not meant to be definitive. It is always recommended to consult the latest research literature for the most current and accurate information."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"CASP1\",",
            "  \"brief_summary\": \"CASP1, or caspase 1, is a gene that encodes an enzyme which belongs to the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspase 1 is involved in the processing of pro-inflammatory cytokines such as interleukin 1 beta (IL1B) and interleukin 18 (IL18). This gene is implicated in the regulation of immune responses and may also have a role in pyroptosis, a form of programmed cell death associated with inflammation.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 4,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 5,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are approximate estimations that may vary depending on the context of the research and literature available as of my knowledge cutoff date. It is essential to consult current scientific literature for the most accurate and updated information on the gene's associations and relevance."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"CASP1\",",
            "  \"brief_summary\": \"CASP1 (Caspase 1) is a gene that encodes for the enzyme caspase-1, which plays a crucial role in the inflammatory processes. This enzyme is involved in the maturation of pro-inflammatory cytokines such as interleukin-1beta (IL-1\u03b2) and interleukin-18 (IL-18), and is a key component of the inflammasome, a complex responsible for the activation of inflammatory responses. Caspase-1 is also involved in pyroptosis, a form of programmed cell death associated with inflammation.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 4,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 7,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 8",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are a general estimate based on the known functions of the CASP1 gene and the typical involvement of caspase-1 in immune responses and diseases. Actual evidence strength might vary based on the latest research and the context of specific diseases or applications."
        ]
    },
    "SAMD9": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"SAMD9\",",
            "  \"brief_summary\": \"SAMD9 (Sterile Alpha Motif Domain Containing 9) is a gene that encodes a protein involved in cellular stress responses, growth regulation, and antiviral responses. Mutations in this gene have been associated with various medical conditions, including MIRAGE syndrome, which is characterized by myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, and enteropathy. The SAMD9 protein is thought to play a role in the innate immune system and may be involved in the regulation of type I interferon responses.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are subjective estimates based on the information available up to the knowledge cutoff date. The actual evidence for each statement can vary, and it is advisable to consult the latest scientific literature for more precise information."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"SAMD9\",",
            "  \"brief_summary\": \"SAMD9, which stands for Sterile Alpha Motif Domain Containing 9, is a protein-coding gene located on chromosome 7. It plays a role in the innate immune response and has been implicated in various cellular processes, including growth regulation and antiviral responses. Mutations in SAMD9 can cause conditions such as MIRAGE syndrome, which involves growth retardation, adrenal insufficiency, and genital abnormalities. SAMD9's function in immune responses, particularly its role in the type I interferon pathway, has been a subject of research, potentially linking it to a range of immune-related diseases.\",",
            "  \"scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that these scores are estimates based on current literature as of 2023, and the understanding of the gene's functions and associations with various processes and diseases may evolve with more research. The scores should be considered as a starting point for evaluating the gene's relevance in different biological contexts and are not definitive."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"SAMD9\",",
            "  \"Brief_summary\": \"SAMD9, which stands for sterile alpha motif domain-containing protein 9, is a gene located on chromosome 7q21. It is involved in the innate immune response and has been implicated in the regulation of antiviral and inflammatory responses. Mutations in this gene are associated with a variety of human diseases, including myelodysplastic syndrome, ataxia-pancytopenia syndrome, and other conditions characterized by growth retardation, immunodeficiency, and increased susceptibility to infections.\",",
            "  \"The gene is associated with type I interferon responses\": 9,",
            "  \"The gene is associated with type II interferon responses\": 4,",
            "  \"The gene is associated with type III interferon responses\": 5,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "}",
            "```"
        ]
    },
    "IFITM1": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"IFITM1\",",
            "  \"brief_summary\": \"Interferon Induced Transmembrane Protein 1 (IFITM1) is a member of the interferon-inducible transmembrane protein family that is known to play a role in antiviral defense, cell adhesion, and immune cell signaling. It is involved in the cellular response to interferon and has been implicated in various biological processes including cell growth regulation, differentiation, and the immune response to viral infections.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 4,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are somewhat subjective and are based on current scientific literature and knowledge as of my last update. The actual evidence might vary, and thus these scores should be considered as suggestive rather than definitive."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"IFITM1\",",
            "  \"Brief_summary\": \"IFITM1 (Interferon Induced Transmembrane Protein 1) is a gene that encodes a protein involved in the body's immune response to viral infections. The IFITM1 protein is a member of the interferon-induced transmembrane protein family, which plays a role in inhibiting the entry and replication of viruses within host cells. IFITM1 is induced by interferon signaling and is known to be involved in antiviral defense mechanisms, particularly against influenza A and other enveloped viruses.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 6,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "**Explanation of Evidence Scores:**",
            "- The high score for type I interferon responses reflects the well-established role of IFITM1 in the response to type I interferons, which are crucial in the antiviral immune response.",
            "- The moderate scores for type II and III interferon responses indicate that while there are associations with these types of interferons, the evidence is less robust or direct compared to type I interferons.",
            "- The relevance to circulating leukocytes' immune biology is given a high score due to the role of IFITM1 in immune cells that are part of the leukocyte population and participate in the immune response.",
            "- The low score for current clinical use as a biomarker reflects the fact that, while IFITM1 may have potential, it is not widely used as a clinical biomarker at this time.",
            "- The potential value as a blood transcriptional biomarker is scored moderately high, suggesting that there is promising evidence for IFITM1's role in reflecting immune activity but more research may be needed to fully establish its use.",
            "- The low score as a known drug target reflects the limited evidence of IFITM1 being directly targeted by therapeutic drugs in clinical use.",
            "- The therapeutic relevance score is moderately high due to IFITM1's role in the immune response, indicating potential for therapeutic intervention in diseases involving the immune system, although it may not be a direct target of current therapies."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"IFITM1\",",
            "  \"Brief_summary\": \"Interferon-induced transmembrane protein 1 (IFITM1) is part of the IFITM family of proteins that mediate antiviral responses and are involved in cell adhesion, immune signaling, and inhibition of virus replication. IFITM1 is induced by interferons and is known to play a role in the innate immune response against various viral infections.\",",
            "  \"The gene is associated with type I interferon responses\": 9,",
            "  \"The gene is associated with type II interferon responses\": 6,",
            "  \"The gene is associated with type III interferon responses\": 5,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ]
    },
    "SP100": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"SP100\",",
            "  \"brief_summary\": \"SP100 (SP100 Nuclear Antigen) is a gene that encodes a nuclear protein that is a component of the PML (promyelocytic leukemia) nuclear body, a subnuclear domain implicated in a variety of cellular processes including transcription, DNA repair, and antiviral defense mechanisms. The protein encoded by this gene is also known to function in the modulation of the immune response and is involved in chromatin-mediated regulation of gene expression.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note: The scores provided above are subjective and are not based on a specific dataset or analysis. They are intended to give a general sense of the consensus in the scientific community regarding the statements at the time of the knowledge cutoff. Actual evidence and consensus may vary, and should always be verified with the latest research."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"SP100\",",
            "  \"brief_summary\": \"SP100 (SP100 Nuclear Antigen) is a gene that encodes a nuclear protein involved in chromatin organization and transcriptional regulation. It is a component of the PML (promyelocytic leukemia) nuclear bodies and plays a role in the cellular response to stress, viral infection, and in the regulation of gene expression. The protein encoded by this gene has been implicated in antiviral defense mechanisms, particularly in relation to the interferon response.\"",
            "}",
            "```",
            "",
            "```json",
            "{",
            "  \"The gene is associated with type I interferon responses\": 8,",
            "  \"The gene is associated with type II interferon responses\": 5,",
            "  \"The gene is associated with type III interferon responses\": 4,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"SP100\",",
            "  \"brief_summary\": \"The SP100 gene encodes a protein that is part of the nuclear body, structures that are involved in gene expression regulation and the innate immune response. The protein encoded by SP100 is known to play a role in chromatin organization and transcriptional regulation and has been implicated in antiviral defense mechanisms, particularly in response to herpes simplex virus infection. The SP100 protein interacts with other proteins such as PML (promyelocytic leukemia protein) and is involved in the formation of PML nuclear bodies, which are important for cellular antiviral responses.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores given are not definitive and should be verified with current scientific research. The scores have been estimated based on general knowledge up to the knowledge cutoff date and might not accurately reflect the most current scientific data."
        ]
    },
    "NT5C3": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"NT5C3\",",
            "  \"brief_summary\": \"NT5C3, also known as 5'-nucleotidase, cytosolic III, is a gene that encodes an enzyme involved in nucleotide metabolism. It catalyzes the dephosphorylation of nucleoside monophosphates to their corresponding nucleosides, thus playing a role in the salvage pathway of nucleotide synthesis. The enzyme encoded by this gene is thought to be involved in maintaining the cellular nucleotide pool.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 2,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 3",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are largely speculative and not based on any specific data sources. They should be interpreted cautiously and supplemented with up-to-date research findings from scientific literature and databases."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "    \"gene_name\": \"NT5C3\",",
            "    \"brief_summary\": \"5'-nucleotidase, cytosolic III (NT5C3), also known as NT5C3A, is an enzyme that in humans is encoded by the NT5C3A gene. This gene encodes a member of the 5'-nucleotidase family, which catalyzes the dephosphorylation of nucleoside monophosphates to nucleosides. The encoded enzyme is a cytosolic enzyme and prefers ribonucleotides as a substrate. It is involved in the metabolism of nucleotides in the cell, which is important for maintaining the balance of nucleotide pools and efficient DNA synthesis. Mutations in this gene have been associated with hereditary hemolytic anemia.\",",
            "    \"evidence_scores\": {",
            "        \"The gene is associated with type I interferon responses\": 3,",
            "        \"The gene is associated with type II interferon responses\": 2,",
            "        \"The gene is associated with type III interferon responses\": 1,",
            "        \"The gene is relevant to circulating leukocytes immune biology\": 5,",
            "        \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "        \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "        \"The gene is a known drug target\": 1,",
            "        \"The gene is therapeutically relevant for diseases involving the immune system\": 3",
            "    }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are not based on specific evidence from scientific literature and may not accurately reflect the current state of knowledge regarding NT5C3. These scores are illustrative and should be verified through a thorough review of the latest research studies."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"NT5C3\",",
            "  \"brief_summary\": \"The gene NT5C3, also known as 5'-nucleotidase, cytosolic III, encodes an enzyme involved in the pyrimidine salvage pathway. It catalyzes the dephosphorylation of pyrimidine 5'-mononucleotides to their corresponding nucleosides. Its activity is important for the regulation of intracellular nucleotide levels and has implications in cellular metabolism and possibly in DNA repair processes.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 2,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 4,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are not based on extensive scientific literature research and are for illustrative purposes. For accurate evidence scores, a thorough literature review would be necessary. The scores reflect a generalized, potential association based on the gene's function and known pathways, but they do not represent definitive evidence."
        ]
    },
    "DTX3L": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"DTX3L\",",
            "  \"brief_summary\": \"The DTX3L gene, also known as 'Deltex E3 Ubiquitin Ligase 3L', encodes a protein that is involved in the regulation of immune responses. It functions as an E3 ubiquitin ligase and is known to interact with the tumor suppressor p53, playing a role in p53-mediated apoptosis. DTX3L is also implicated in antiviral responses and may modulate cellular processes by ubiquitinating specific target proteins for degradation.\"",
            "}",
            "{",
            "  \"The gene is associated with type I interferon responses\": 6,",
            "  \"The gene is associated with type II interferon responses\": 4,",
            "  \"The gene is associated with type III interferon responses\": 3,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "}",
            "```",
            "",
            "Please note that the scores provided are estimates based on current scientific understanding and available literature. These scores may change as new research emerges."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"DTX3L\",",
            "  \"Brief_summary\": \"DTX3L, also known as B-lymphoma and BAL-associated protein (BBAP), is a member of the Deltex family of E3 ubiquitin ligases. It plays a role in the regulation of the ubiquitination and degradation of certain proteins, which is important for various cellular functions. DTX3L has been implicated in the regulation of the immune response, including the type I interferon signaling pathway, and may be involved in the pathogenesis of certain cancers.\",",
            "  \"The gene is associated with type I interferon responses\": 7,",
            "  \"The gene is associated with type II interferon responses\": 4,",
            "  \"The gene is associated with type III interferon responses\": 3,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "}",
            "```",
            "",
            "Please note that the scores provided are approximations based on known scientific literature up to the knowledge cutoff date. These scores might change as new research becomes available. It is also important to verify these scores with the most current scientific evidence."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"DTX3L\",",
            "  \"Brief_summary\": \"DTX3L, also known as Deltex 3 Like E3 Ubiquitin Ligase, is a protein-coding gene involved in the regulation of various cellular processes including cell fate decisions, cell cycle progression, and possibly the regulation of cell death through its E3 ubiquitin ligase activity. It has been implicated in the ubiquitination and degradation of target proteins, and it may play a role in the immune response.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the evidence scores provided above are hypothetical and are meant to illustrate how the JSON format might be used to convey information regarding the evidence supporting various statements about a gene. In practice, these scores would need to be derived from a detailed review of the scientific literature and databases."
        ]
    },
    "PSMB9": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"PSMB9\",",
            "  \"Brief_summary\": \"PSMB9, also known as the proteasome subunit beta type-9, is a component of the immunoproteasome which plays a pivotal role in the non-lysosomal degradation of proteins. It is involved in the generation of antigenic peptides that are presented on MHC class I molecules, and is thus important for the immune response to pathogens and in immune surveillance. The PSMB9 gene is also regulated by interferon-gamma and can be upregulated in response to inflammatory signals.\",",
            "  \"The gene is associated with type I interferon responses\": 4,",
            "  \"The gene is associated with type II interferon responses\": 8,",
            "  \"The gene is associated with type III interferon responses\": 3,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"PSMB9\",",
            "  \"Brief_summary\": \"PSMB9, also known as \u03b21i or LMP2, is a gene that encodes a subunit of the immunoproteasome. The immunoproteasome is a specialized form of the proteasome that plays a role in antigen processing for the major histocompatibility complex (MHC) class I pathway. It is involved in the degradation of ubiquitinated proteins, which is important for various cellular processes including cell cycle regulation, signal transduction, and immune responses. PSMB9 is induced by interferon-gamma and is often associated with immune system diseases.\",",
            "  \"The gene is associated with type I interferon responses\": 3,",
            "  \"The gene is associated with type II interferon responses\": 8,",
            "  \"The gene is associated with type III interferon responses\": 2,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"PSMB9\",",
            "  \"Brief_summary\": \"The PSMB9 gene, also known as LMP2, encodes a component of the immunoproteasome. It is involved in the processing of class I MHC peptides, a critical part of the immune system that presents antigenic peptides to T cells. Variations in this gene are associated with certain autoimmune diseases and may influence the immune response to infectious agents.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 8,",
            "    \"The gene is associated with type III interferon responses\": 5,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 4,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ]
    },
    "TMEM140": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "    \"gene_name\": \"TMEM140\",",
            "    \"Brief_summary\": \"TMEM140, also known as transmembrane protein 140, is a gene that encodes a protein whose exact function is not well understood. However, it is thought to be involved in cellular processes such as apoptosis and may have a role in the regulation of cell death.\",",
            "    \"The gene is associated with type I interferon responses\": 1,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 2,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "}",
            "```",
            "",
            "Please note that the information provided here is general, and the scores given for the statements are indicative based on limited knowledge as of early 2023. Further research and up-to-date scientific evidence are required to accurately score these statements. The scores provided reflect a conservative estimate of the association and relevance of TMEM140 with the given statements, considering the lack of widespread evidence or significant research findings."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "    \"gene_name\": \"TMEM140\",",
            "    \"brief_summary\": \"TMEM140, also known as Transmembrane Protein 140, is a protein that in humans is encoded by the TMEM140 gene. The function of this gene has not been fully characterized, but it is known to be expressed in several tissues and may be involved in cellular processes such as apoptosis. Research on this gene is ongoing, and it may have implications in various biological functions and disease states.\",",
            "    \"evidence_scores\": {",
            "        \"The gene is associated with type I interferon responses\": 3,",
            "        \"The gene is associated with type II interferon responses\": 2,",
            "        \"The gene is associated with type III interferon responses\": 1,",
            "        \"The gene is relevant to circulating leukocytes immune biology\": 5,",
            "        \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "        \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "        \"The gene is a known drug target\": 0,",
            "        \"The gene is therapeutically relevant for diseases involving the immune system\": 3",
            "    }",
            "}",
            "```",
            "",
            "Please note that the scores provided are hypothetical and for illustrative purposes only. They are not based on specific scientific evidence or literature and should not be used as a basis for research or clinical decisions. The actual evidence for TMEM140's involvement in these areas may vary and should be verified through current research and literature."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"TMEM140\",",
            "  \"Brief_summary\": \"TMEM140, also known as Transmembrane Protein 140, is a gene that encodes a protein of the same name. The function of this protein is not well-characterized, but it is thought to be involved in cellular processes due to its localization within the cell membrane. Its role in the immune system or as a biomarker has been the subject of research, but conclusive functions and associations are still under investigation.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 3,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 4,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 3",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are hypothetical and are meant to serve as an example. The actual evidence for the associations of the TMEM140 gene with these statements would require an in-depth review of the scientific literature. The summary provided is also a general description and may not reflect the most current knowledge. It is advisable to consult recent research for the most accurate and up-to-date information regarding the TMEM140 gene."
        ]
    },
    "RNF213": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"RNF213\",",
            "  \"brief_summary\": \"RNF213 is a gene that encodes for a protein known as ring finger protein 213, which is thought to play a role in vascular remodeling and angiogenesis. Mutations in RNF213 have been implicated in Moyamoya disease, a rare cerebrovascular disorder characterized by the progressive stenosis of arteries in the brain. The protein has E3 ubiquitin-protein ligase activity and is involved in various biological processes, including the response to cellular stress.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 1,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 3,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 2,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are somewhat speculative, as they are based on a general understanding of the gene's functions and known associations with disease and immune responses as of my last update. The association of RNF213 with various types of interferon responses and its potential use as a biomarker or drug target would require more specific research and evidence, which could alter these scores."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"RNF213\",",
            "  \"brief_summary\": \"RNF213 is a gene that encodes for a protein known as ring finger protein 213. This protein has E3 ubiquitin-protein ligase activity and is thought to be involved in various processes including angiogenesis and immune responses. Mutations in RNF213 are associated with Moyamoya disease, a progressive cerebrovascular disorder. The function of RNF213 in immune responses and its potential role in other diseases are subjects of ongoing research.\",",
            "  \"gene_association_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 2,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 4,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 3",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided for the gene association statements are based on a general interpretation of available scientific data as of my knowledge cutoff date in 2023. They should not be considered definitive or used as a sole source for decision-making in clinical or research settings. These scores reflect the likelihood and evidence of the gene's association with the given statements, with higher scores indicating stronger evidence. The information may evolve as new research emerges."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"RNF213\",",
            "  \"brief_summary\": \"RNF213 is a gene that encodes for a protein called ring finger protein 213. It has been implicated in certain vascular disorders, particularly Moyamoya disease, which is characterized by the progressive stenosis of cerebral arteries. The RNF213 protein possesses ATPase and E3 ligase activities, suggesting a role in cellular processes that may involve protein ubiquitination. However, the full spectrum of its biological functions and the mechanisms by which mutations lead to disease are not fully understood.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 2,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 5,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 4",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are a hypothetical representation based on a general understanding of the gene RNF213 and are not derived from specific scientific evidence. These scores should be validated with further research and clinical data."
        ]
    },
    "TRIM21": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"TRIM21\",",
            "  \"brief_summary\": \"The TRIM21 gene (Tripartite Motif Containing 21) encodes an E3 ubiquitin-protein ligase which plays a role in innate immune responses. It is involved in the process of targeting foreign cytosolic DNA and viral RNA for degradation. TRIM21 is also known as Ro52 and is implicated in the pathogenesis of several autoimmune diseases, where autoantibodies against TRIM21 are often present.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 6,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are estimated based on current scientific knowledge and could vary as new research emerges. The scores reflect the degree to which the statement is supported by scientific evidence, with 0 indicating low evidence and 10 indicating high evidence."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "Here is the information you requested in JSON format:",
            "",
            "```json",
            "{",
            "  \"gene_name\": \"TRIM21\",",
            "  \"brief_summary\": \"The TRIM21 gene, also known as Ro52 or SS-A, encodes for an E3 ubiquitin-protein ligase that plays a role in the immune response. TRIM21 is involved in the ubiquitination and degradation of immune signaling proteins, thereby regulating the strength and duration of the immune response. It is also known to be an autoantigen in autoimmune diseases, such as Sjogren's syndrome and systemic lupus erythematosus.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that these scores are approximations based on current scientific knowledge up to early 2023 and may not reflect the most current research. The scores are subjective interpretations of the available evidence and should be used as a guide rather than definitive statements."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"TRIM21\",",
            "  \"Brief_summary\": \"TRIM21 (Tripartite Motif Containing 21), also known as Ro52 or SS-A, is a protein that in humans is encoded by the TRIM21 gene. It is an E3 ubiquitin-protein ligase that plays a role in innate immune response by acting as an autoantigen and as an intracellular sensor of viral replication. TRIM21 is involved in the process of targeting viral antigens for proteasomal degradation and promotes the activation of antiviral response pathways. It has been implicated in various autoimmune diseases, such as Sj\u00f6gren's syndrome and systemic lupus erythematosus.\"",
            "}",
            "```",
            "",
            "```json",
            "{",
            "  \"The gene is associated with type I interferon responses\": 8,",
            "  \"The gene is associated with type II interferon responses\": 6,",
            "  \"The gene is associated with type III interferon responses\": 5,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "  \"The gene is a known drug target\": 3,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 8",
            "}",
            "```"
        ]
    },
    "CHMP5": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"CHMP5\",",
            "  \"brief_summary\": \"CHMP5, or Charged Multivesicular Body Protein 5, is a component of the endosomal sorting complex required for transport III (ESCRT-III) which is involved in the degradation of surface receptor proteins and the sorting of endosomal cargo proteins into multivesicular bodies (MVBs). The ESCRT machinery is crucial for processes such as the formation of multivesicular bodies (MVBs), autophagy, and the budding of certain viruses. CHMP5 has been implicated in the negative regulation of the signaling cascade that leads to the activation of NF-kappaB, a key regulator of immune responses.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 3,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 5,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 4",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are hypothetical and meant to serve as an example of how evidence might be scored. Actual evidence scores should be derived from a thorough review of the scientific literature and current research data."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"CHMP5\",",
            "  \"Brief_summary\": \"CHMP5, or Charged Multivesicular Body Protein 5, is a component of the ESCRT-III complex, which is involved in the degradation of surface receptor proteins and the sorting of endosomal cargo proteins into multivesicular bodies. The ESCRT machinery is also implicated in the final stages of cytokinesis and in the budding of certain viruses from the plasma membrane. CHMP5 plays a role in the endosomal sorting pathway for the degradation of transmembrane proteins and has been implicated in the regulation of the immune response through its interactions with the STAMBP/STAM and VPS4 complexes.\",",
            "  \"The gene is associated with type I interferon responses\": 2,",
            "  \"The gene is associated with type II interferon responses\": 2,",
            "  \"The gene is associated with type III interferon responses\": 1,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 4,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 3",
            "}",
            "```",
            "",
            "Please note that the scores provided are a rough estimate and may vary depending on the latest research findings. For the most current and precise evaluation, a thorough review of the scientific literature is recommended."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "{",
            "  \"gene_name\": \"CHMP5\",",
            "  \"Brief_summary\": \"CHMP5, or Charged Multivesicular Body Protein 5, is a component of the endosomal sorting complex required for transport-III (ESCRT-III), which is involved in the degradation and recycling of membrane proteins, and the formation of multivesicular bodies. CHMP5 is essential for the late endosome to lysosome trafficking and plays a role in the regulation of cell surface receptor degradation. It is also implicated in the regulation of certain signaling pathways and may have a role in the immune response.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "",
            "Please note that the scores assigned to the statements are estimations based on current knowledge and may change with new research. Always consult up-to-date scientific literature or databases for the most current information regarding gene functions and associations."
        ]
    },
    "STAT2": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"STAT2\",",
            "  \"brief_summary\": \"STAT2 (Signal Transducer And Activator Of Transcription 2) is a member of the STAT family of transcription factors. It is predominantly involved in the signal transduction pathways activated by type I interferons (IFNs), such as IFN-alpha and IFN-beta, which are critical for the cellular response to viral infection and other stimuli. Upon activation by type I IFNs, STAT2 forms a complex with STAT1 and IRF9, creating the ISGF3 complex, which translocates to the nucleus and binds to IFN-stimulated response elements (ISREs) in the promoters of IFN-stimulated genes (ISGs), initiating their transcription.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 5,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"STAT2\",",
            "  \"brief_summary\": \"STAT2 (Signal Transducer And Activator Of Transcription 2) is a member of the STAT protein family. It is a key component of the interferon signaling pathway and is activated in response to type I interferon (IFN-alpha and IFN-beta) and type III interferon (IFN-lambda). Upon activation, STAT2 forms a complex with STAT1 and IRF9, known as the ISGF3 complex, which translocates to the nucleus to initiate the transcription of interferon-stimulated genes (ISGs). These genes play a critical role in the antiviral response, antiproliferative effects, and immune surveillance. STAT2 is predominantly involved in the immune response to viral infections and contributes to the regulation of cell growth and apoptosis.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 9,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"STAT2\",",
            "  \"brief_summary\": \"STAT2 (Signal Transducer And Activator Of Transcription 2) is a member of the STAT family of transcription factors. It is crucially involved in the cellular response to type I interferons (IFNs), such as IFN-alpha and IFN-beta, and to a lesser extent, type III IFNs. Upon activation by interferon receptors, STAT2 forms a complex with STAT1 and IRF9 to create the ISGF3 transcription factor complex, which enters the nucleus to induce the expression of interferon-stimulated genes (ISGs). These genes play significant roles in antiviral defense, immune surveillance, and other cellular processes. STAT2's functions are essential for the innate immune response and the maintenance of antiviral states in cells.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 7,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 8",
            "  }",
            "}",
            "```",
            "",
            "The scores provided for each statement are approximations based on current scientific understanding and may vary as new research emerges."
        ]
    },
    "ACTA2": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"ACTA2\",",
            "  \"Brief_summary\": \"ACTA2 encodes the actin, alpha 2, smooth muscle, aorta, a protein which is a major constituent of the contractile apparatus in smooth muscle cells. Mutations in this gene are associated with several disorders including coronary artery disease, thoracic aortic aneurysms and dissections, and Moyamoya disease.\",",
            "  \"The gene is associated with type I interferon responses\": 1,",
            "  \"The gene is associated with type II interferon responses\": 1,",
            "  \"The gene is associated with type III interferon responses\": 1,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 2,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "  \"The gene is a known drug target\": 0,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "}",
            "```",
            "",
            "Please note that the scores provided are not based on extensive evidence or literature review and are to be taken as indicative based on general knowledge. The scores reflect a general understanding that while ACTA2 has roles in smooth muscle function and is associated with various diseases, its direct involvement in interferon responses and as a biomarker or drug target in immune system diseases is not highly established in the literature as of the knowledge cutoff date."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"ACTA2\",",
            "  \"Brief_summary\": \"The ACTA2 gene encodes a protein called actin, alpha 2, which is a smooth muscle actin found in vascular smooth muscle cells. It is involved in various processes including muscle contraction, cell motility, and maintenance of cell shape and integrity. Mutations in ACTA2 can lead to a variety of vascular diseases, such as thoracic aortic aneurysms and dissections.\",",
            "  \"The gene is associated with type I interferon responses\": 1,",
            "  \"The gene is associated with type II interferon responses\": 1,",
            "  \"The gene is associated with type III interferon responses\": 1,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 2,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"ACTA2\",",
            "  \"brief_summary\": \"ACTA2 (Actin, Alpha 2, Smooth Muscle, Aorta) is a gene that codes for a protein involved in the contractile apparatus of smooth muscle cells. It plays a crucial role in maintaining the integrity and function of vascular smooth muscle tissue and is involved in various cellular processes including muscle contraction, cell motility, and maintenance of cell shape. Mutations in ACTA2 are associated with diseases such as thoracic aortic aneurysms and dissections (TAAD), as well as other vascular pathologies.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 1,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 2,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are based on a general knowledge of the gene's functions and associations. The scores might not reflect the very latest research findings. The scores are subjective estimations and should only be used as a starting point for further investigation. They are not based on a systematic review. The evidence for ACTA2's role in interferon responses and immune biology is not well-established, hence the lower scores. The potential value of ACTA2 as a biomarker is recognized in the context of vascular diseases, which is reflected in slightly higher scores. The scores for drug target and therapeutic relevance are low due to the limited evidence of ACTA2 being directly targeted by drugs or therapies for immune-related diseases."
        ]
    },
    "PHF11": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"PHF11\",",
            "  \"Brief_summary\": \"PHF11 (Plant HomeoDomain Finger Protein 11) is a Protein Coding gene. It is known to be involved in immune system processes and has been studied in the context of allergic diseases such as asthma. The protein encoded by PHF11 is believed to play a role in the regulation of immune responses, and variations in this gene have been associated with differences in serum IgE levels.\",",
            "  \"The gene is associated with type I interferon responses\": 3,",
            "  \"The gene is associated with type II interferon responses\": 2,",
            "  \"The gene is associated with type III interferon responses\": 1,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "}",
            "```",
            "",
            "Please note that the provided scores are hypothetical and are meant to illustrate the JSON format. For accurate evidence-based scores, a thorough review of the scientific literature and clinical data would be required."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"PHF11\",",
            "  \"Brief_summary\": \"PHF11 (Plant Homeodomain Finger Protein 11) is a gene that encodes a protein thought to be involved in regulating gene expression. It has been studied in the context of immune system function, particularly in relation to atopic dermatitis, asthma, and other allergic diseases. The PHF11 protein contains a plant homeodomain (PHD) finger, which is a common motif in proteins that interact with chromatin and can influence transcriptional regulation.\",",
            "  \"Evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 3,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are not based on an exhaustive review of scientific literature and should not be taken as definitive statements about the gene's function or clinical relevance. Instead, they are estimated scores intended to provide a rough assessment based on available knowledge up to the cutoff in 2023. For accurate and up-to-date information, a detailed review of the current scientific literature is recommended."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"PHF11\",",
            "  \"Brief_summary\": \"PHF11 (Plant Homeodomain Finger Protein 11) is a gene that encodes a protein with potential roles in regulating T-cell apoptosis and modulating other immune responses. It has been studied in the context of asthma and other allergic diseases.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 4,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 3",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are subjective and are based on current scientific understanding as of my knowledge cutoff date. They reflect a general sense of the evidence available for each statement but are not based on a systematic review. The evidence for these statements can change as new research is published."
        ]
    },
    "ZNFX1": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"ZNFX1\",",
            "  \"brief_summary\": \"The ZNFX1 gene encodes a member of the zinc finger protein family that may function in transcriptional regulation. Little is currently known about its precise biological role, but it may be involved in antiviral mechanisms, including the recognition of viral nucleic acids and the regulation of immune responses.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 4,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 4",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are hypothetical and designed for illustrative purposes. The actual evidence supporting these statements can vary and should be derived from the latest scientific research."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"ZNFX1\",",
            "  \"brief_summary\": \"ZNFX1, or Zinc Finger NFX1-Type Containing 1, is a gene that encodes a protein thought to be involved in the immune response and in the defense against viral infections. The exact function of ZNFX1 is not fully understood, but it may play a role in RNA processing or in the regulation of gene expression related to the immune system.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 3",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are based on a hypothetical assessment due to lack of specific data about ZNFX1 as of my knowledge cutoff date in early 2023. The evidence may vary as new research emerges, and these scores should not be taken as a definitive evaluation but rather as an example. For precise and current information, further literature review and scientific research are required."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"ZNFX1\",",
            "  \"Brief_summary\": \"ZNFX1 (Zinc Finger NFX1-Type Containing 1) is a gene that encodes a protein which is thought to be involved in antiviral responses, particularly in the recognition of viral nucleic acids. The ZNFX1 protein contains zinc finger motifs that may be important for its function in the innate immune system.\",",
            "  \"Evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are illustrative and not based on specific scientific literature. They are meant to serve as an example of how such a JSON structure might look. To derive accurate scores, a thorough review of the current research literature on ZNFX1 would be necessary."
        ]
    },
    "IFI16": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"IFI16\",",
            "  \"Brief_summary\": \"Interferon gamma-inducible protein 16 (IFI16) is a member of the HIN-200 family of proteins that function in the regulation of transcription and as sensors of foreign DNA in the innate immune response. It is involved in antiviral responses, particularly in recognizing viral DNA in the cytoplasm and promoting the induction of type I interferons. IFI16 also plays a role in regulating cell proliferation and can act as a suppressor of tumor growth.\",",
            "  \"The gene is associated with type I interferon responses\": 9,",
            "  \"The gene is associated with type II interferon responses\": 7,",
            "  \"The gene is associated with type III interferon responses\": 5,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```",
            "",
            "Please note that the scores provided are based on current scientific understanding as of my knowledge cutoff date in early 2023 and are subjective. They are intended to give a general sense of the strength of evidence but are not definitive. Further research and expert consultation would be necessary to provide accurate, up-to-date evaluations."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"IFI16\",",
            "  \"Brief_summary\": \"IFI16 (Interferon Gamma Inducible Protein 16) is a gene that encodes a protein involved in the innate immune response. This protein functions as an intracellular sensor of viral DNA and can activate inflammatory and antiviral responses, including the induction of type I interferons. IFI16 is also implicated in the regulation of cell proliferation, apoptosis, and the DNA damage response.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 6,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are based on a general scientific understanding up to the knowledge cutoff date and should not be taken as definitive evidence without consulting the latest research and expert opinions."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"IFI16\",",
            "  \"brief_summary\": \"The IFI16 gene encodes a protein that is involved in the innate immune system. It is part of the pyrin and HIN domain (PYHIN) family and is known for its role in sensing foreign DNA in the cytoplasm and initiating an immune response. IFI16 is also implicated in the regulation of cell proliferation, apoptosis, and the activation of inflammasomes.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 6,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```"
        ]
    },
    "ADAR": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"ADAR\",",
            "  \"Brief_summary\": \"ADAR (Adenosine Deaminase Acting on RNA) is a gene that encodes for an enzyme involved in RNA editing by site-specific deamination of adenosines, converting them to inosines in double-stranded RNA (dsRNA) substrates. This editing process can result in the alteration of the RNA's coding properties and affect gene expression. ADAR is known to play a role in the immune response and has been implicated in antiviral defense mechanisms, as well as in various neurological disorders.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 4,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided for the statements are based on a general understanding of the gene's functions and its roles in the immune system. These scores do not represent definitive evidence and could change as new research emerges. The scores are meant to provide a rough estimate of the current state of knowledge regarding the various aspects of the ADAR gene."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "    \"gene_name\": \"ADAR\",",
            "    \"Brief_summary\": \"ADAR (Adenosine Deaminase Acting on RNA) is a gene that encodes for proteins involved in RNA editing, specifically the conversion of adenosine to inosine in double-stranded RNA (dsRNA) substrates. This editing can alter the coding properties of mRNAs and affect gene expression. ADAR proteins have been implicated in the development and functioning of the nervous system as well as in innate immune responses to viral infections.\",",
            "    \"evidence_scores\": {",
            "        \"The gene is associated with type I interferon responses\": 8,",
            "        \"The gene is associated with type II interferon responses\": 5,",
            "        \"The gene is associated with type III interferon responses\": 4,",
            "        \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "        \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "        \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "        \"The gene is a known drug target\": 2,",
            "        \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "    }",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"ADAR\",",
            "  \"Brief_summary\": \"ADAR (Adenosine Deaminase Acting on RNA) is a gene that encodes for an enzyme responsible for the editing of RNA molecules by converting adenosine to inosine within double-stranded RNA substrates. This editing process can lead to alterations in the coding properties of RNAs and affect their stability and localization. ADAR is involved in the regulation of gene expression and has been implicated in immune system functioning, particularly in the response to viral infections.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 3,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are a rough estimation based on general knowledge in the field up to my knowledge cutoff in 2023. Actual evidence for each statement may vary, and you should consult the latest research for the most accurate and up-to-date information."
        ]
    },
    "IRF9": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"IRF9\",",
            "  \"brief_summary\": \"IRF9 (Interferon Regulatory Factor 9) is a member of the interferon regulatory transcription factor (IRF) family. It is involved in the regulation of type I interferon-stimulated genes and plays a crucial role in the interferon signaling pathway. IRF9 forms a complex with STAT1 and STAT2 proteins upon interferon activation, known as ISGF3, which translocates to the nucleus and binds to the interferon-stimulated response element (ISRE) to activate the transcription of interferon-stimulated genes (ISGs). These genes are involved in antiviral responses, immunomodulation, and other biological processes related to the immune response.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 8,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"IRF9\",",
            "  \"brief_summary\": \"IRF9 (Interferon Regulatory Factor 9) is a member of the interferon regulatory transcription factor (IRF) family. IRF9 is known for its role in the type I interferon signaling pathway. It forms a complex with STAT1 and STAT2, known as ISGF3, which is critical for the transcriptional activation of interferon-stimulated genes (ISGs) that are involved in the antiviral response. IRF9 is also involved in the activation of genes regulated by type I, type II, and type III interferons, playing a significant role in the regulation of the immune response to viral infections.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 7,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"IRF9\",",
            "  \"brief_summary\": \"IRF9 (Interferon Regulatory Factor 9) is a transcriptional regulator playing a crucial role in the type I interferon signaling pathway. Upon virus infection, IRF9 forms a complex with STAT1 and STAT2, which is known as the ISGF3 complex, and translocates to the nucleus to activate the expression of interferon-stimulated genes (ISGs), driving the antiviral response. IRF9 is also involved in other biological processes, including cell growth regulation and immune responses.\"",
            "}",
            "```",
            "",
            "```json",
            "{",
            "  \"The gene is associated with type I interferon responses\": 10,",
            "  \"The gene is associated with type II interferon responses\": 3,",
            "  \"The gene is associated with type III interferon responses\": 7,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ]
    },
    "TAP1": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"TAP1\",",
            "  \"Brief_summary\": \"The TAP1 gene (Transporter 1, ATP Binding Cassette Subfamily B Member) encodes a protein that is involved in the presentation of antigenic peptides to the immune system. TAP1, along with TAP2, forms a transporter complex that is responsible for the translocation of peptides from the cytosol into the endoplasmic reticulum, where they bind to major histocompatibility complex (MHC) class I molecules. The peptide-MHC I complexes are then presented on the cell surface for recognition by CD8+ T cells. This process is essential for the immune system to detect and respond to pathogens and is also involved in tumor surveillance.\",",
            "  \"The gene is associated with type I interferon responses\": 8,",
            "  \"The gene is associated with type II interferon responses\": 9,",
            "  \"The gene is associated with type III interferon responses\": 4,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 10,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 5,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 3,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"TAP1\",",
            "  \"brief_summary\": \"The TAP1 gene (Transporter 1, ATP Binding Cassette Subfamily B Member) is involved in the transport of antigens from the cytoplasm to the endoplasmic reticulum, a crucial step in the process of antigen presentation on MHC class I molecules. This function is essential for the immune system to recognize and respond to viral infections and other intracellular pathogens. Mutations in TAP1 can lead to immune system deficiencies and are associated with certain autoimmune diseases.\"",
            "}",
            "```",
            "",
            "```json",
            "{",
            "  \"The gene is associated with type I interferon responses\": 7,",
            "  \"The gene is associated with type II interferon responses\": 8,",
            "  \"The gene is associated with type III interferon responses\": 4,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"TAP1\",",
            "  \"brief_summary\": \"The TAP1 gene (Transporter 1, ATP Binding Cassette Subfamily B Member) is involved in the process of antigen presentation. It encodes a protein that is part of the ATP-binding cassette (ABC) transporter family and works in tandem with TAP2 to transport peptides from the cytosol into the endoplasmic reticulum. These peptides are then loaded onto major histocompatibility complex (MHC) class I molecules for presentation to CD8+ T cells. TAP1 plays a crucial role in the immune response against virus-infected and malignantly transformed cells.\"",
            "}",
            "```",
            "",
            "```json",
            "{",
            "  \"The gene is associated with type I interferon responses\": 7,",
            "  \"The gene is associated with type II interferon responses\": 8,",
            "  \"The gene is associated with type III interferon responses\": 4,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```",
            "",
            "Please note that the scores provided are subjective and are based on general knowledge of the gene's function and research literature available up to early 2023. For precise and up-to-date information, detailed literature and clinical studies should be consulted."
        ]
    },
    "SHISA5": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"SHISA5\",",
            "  \"Brief_summary\": \"SHISA5, also known as Shisa-5, is a member of the Shisa family and is known to play a role in regulating the maturation of specific ion channels and receptors in the endoplasmic reticulum. The gene is expressed in a variety of tissues and has been studied in the context of neurological development and function.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 2,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 3,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided in the `evidence_scores` section are hypothetical and for illustration purposes only. Actual evidence for each statement would need to be reviewed from scientific literature or databases to provide accurate scores."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"SHISA5\",",
            "  \"Brief_summary\": \"The SHISA5 gene encodes a protein that is thought to be involved in the modulation of ion channels, such as voltage-gated calcium channels and AMPA-type glutamate receptors. Its role in immune responses and as a biomarker or drug target is less well characterized and may require further research to clarify its functions in these contexts.\",",
            "  \"The gene is associated with type I interferon responses\": 2,",
            "  \"The gene is associated with type II interferon responses\": 2,",
            "  \"The gene is associated with type III interferon responses\": 2,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 3,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 3",
            "}",
            "```",
            "",
            "Please note that the scores provided are estimations based on limited information and may not reflect the most current research. They are intended to provide a rough gauge of the evidence supporting each statement. Actual scores may vary based on new research and findings."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"SHISA5\",",
            "  \"brief_summary\": \"SHISA5, also known as Shisa family member 5, is a gene that encodes the Shisa5 protein. This protein is involved in the modulation of signaling pathways during development. It is known to interact with the Wnt and FGF signaling pathways and may play a role in neural development and function.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 2,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 3,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are hypothetical and for illustrative purposes only. Accurate scoring would require a thorough review of the current scientific literature on SHISA5."
        ]
    },
    "TDRD7": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"TDRD7\",",
            "  \"Brief_summary\": \"TDRD7, known as Tudor Domain Containing 7, is a gene involved in the organization of RNA granules and stress granules, with specific roles in the development of the lens and retina in the eye. Mutations in TDRD7 have been associated with congenital cataracts and other ocular defects. The gene encodes for a protein that is a component of ribonucleoprotein complexes and may have functions related to post-transcriptional regulation of gene expression.\",",
            "  \"The gene is associated with type I interferon responses\": 1,",
            "  \"The gene is associated with type II interferon responses\": 1,",
            "  \"The gene is associated with type III interferon responses\": 1,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 4,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "}",
            "```",
            "",
            "The scores provided are estimates based on the gene's known functions, its association with immune responses, and potential relevance to disease. These scores may change as new research emerges."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"TDRD7\",",
            "  \"brief_summary\": \"TDRD7 is a gene that encodes for the Tudor domain-containing protein 7. It is involved in the formation of cytoplasmic RNA granules known as stress granules, which are implicated in RNA processing and stress responses. Mutations in TDRD7 have been associated with cataract formation and other ocular disorders.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 1,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 3,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 2,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are for illustrative purposes and might not fully reflect the current scientific evidence. They are meant to give an impression of relative levels of evidence but are not based on a systematic review. For the most accurate and up-to-date information, a detailed literature review would be necessary."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"TDRD7\",",
            "  \"Brief_summary\": \"TDRD7, or Tudor Domain Containing 7, is a gene that encodes for a protein involved in the formation of ribonucleoprotein particles that play a role in RNA processing and stability. Mutations in TDRD7 are known to be associated with cataract formation and other ocular defects.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 1,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 5,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 2",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided for the statements are based on a hypothetical assessment of available knowledge and should not be considered definitive. The actual evidence levels may vary, and further research could alter these scores. Always consult the latest scientific literature for the most current information."
        ]
    },
    "IL1F7": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"IL1F7\",",
            "  \"brief_summary\": \"The IL1F7 gene, also known as IL37, belongs to the interleukin 1 cytokine family. This gene encodes a member of the interleukin 1 cytokine family which is known for its anti-inflammatory properties and plays a role in regulating immune and inflammatory responses. The encoded protein can modulate the activity of macrophages and is involved in the balance of pro-inflammatory and anti-inflammatory cytokines.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 2,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Note: The scores provided are estimates based on current scientific knowledge, and the actual evidence could vary. These scores are not definitive and should be used as a general guide to the level of evidence supporting each statement."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"IL1F7\",",
            "  \"brief_summary\": \"The IL1F7 gene, also known as IL37, encodes for the interleukin-37 protein, which is a member of the interleukin 1 cytokine family. This cytokine plays a role in immune regulation by downregulating inflammation and the innate immune response. It is expressed in various tissues and can influence the production of other cytokines. IL1F7 is involved in modulating the inflammatory and immune responses, and it has been implicated in anti-inflammatory pathways.\",",
            "  \"associations\": {",
            "    \"The gene is associated with type I interferon responses\": 3,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided in the JSON are based on a general understanding of the gene's functions and roles in immune responses. Actual evidence may vary, and these scores should be validated with current scientific research and clinical data for accuracy."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"IL1F7\",",
            "  \"brief_summary\": \"IL1F7, also known as Interleukin 1 family, member 7 (IL-37), is a member of the interleukin 1 cytokine family. This gene encodes a cytokine that functions as a down-regulator of inflammation and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 3,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are hypothetical and for illustrative purposes only. To obtain accurate evidence scores, a thorough review of the latest scientific literature and clinical trial data is required. The scores may change as new research becomes available."
        ]
    },
    "PARP9": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"PARP9\",",
            "  \"brief_summary\": \"PARP9, also known as Poly [ADP-ribose] polymerase 9, is a member of the PARP family of proteins. This gene encodes an enzyme that is involved in the modification of proteins through ADP-ribosylation, a post-translational modification. PARP9 has been implicated in various cellular processes, including DNA damage repair, cell death, and immune responses. It is also known to interact with DTX3L to form a complex that has a role in the antiviral immune response and the regulation of inflammation.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 4,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are somewhat arbitrary, as the actual evidence supporting these statements would require a detailed review of scientific literature and current research, which can change over time. The scores are based on a general understanding of the gene's roles and should not be considered definitive assessments."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"PARP9\",",
            "  \"Brief_summary\": \"PARP9, or Poly [ADP-ribose] polymerase family member 9, is a gene that encodes a protein involved in DNA repair and cellular stress responses. It is a member of the PARP family of proteins and has been implicated in various immunological processes. The protein is known to interact with DTX3L to form a complex that is involved in the regulation of the immune response and has been suggested to play a role in the pathogenesis of certain cancers and autoimmune diseases.\",",
            "",
            "  \"The gene is associated with type I interferon responses\": 8,",
            "  \"The gene is associated with type II interferon responses\": 5,",
            "  \"The gene is associated with type III interferon responses\": 3,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 4,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"PARP9\",",
            "  \"brief_summary\": \"PARP9, or Poly [ADP-ribose] polymerase 9, is a protein-coding gene involved in the DNA damage response and repair mechanisms. It has been implicated in various cellular processes including immune responses, particularly in the context of viral infections. PARP9 forms a complex with DTX3L to regulate interferon-stimulated gene expression and may influence the activity of macrophages and other immune cells.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 6,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```"
        ]
    },
    "SP110": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"SP110\",",
            "  \"brief_summary\": \"The SP110 gene encodes a nuclear body protein that may have a role in the innate immune response. Variants of this gene have been associated with susceptibility to infectious diseases and may also be involved in the regulation of gene expression within the immune system.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores above are not based on specific data sources and are provided as a hypothetical example. Actual evidence scores can vary based on current research and scientific findings. It is always recommended to consult the latest literature and databases for updated information on gene functions and associations."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"SP110\",",
            "  \"brief_summary\": \"SP110 is a gene that encodes a leukocyte-specific nuclear body component which functions as a transcriptional coactivator that plays a crucial role in the regulation of gene expression during immune responses. It is involved in the innate immune system and has been implicated in the control of viral infections and the regulation of interferon-inducible genes.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are estimates and not based on specific literature sources. They are meant to serve as a hypothetical example of how one might score the evidence for various statements about the SP110 gene. For actual research purposes, a thorough literature review and consultation with current research databases would be necessary to provide accurate and up-to-date evidence scores."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"SP110\",",
            "  \"brief_summary\": \"SP110 is a gene that encodes a leukocyte nuclear body protein, which may function as a nuclear hormone receptor transcriptional coactivator that appears to be involved in the innate immune response. Variants of SP110 have been associated with susceptibility to infectious diseases such as tuberculosis, as well as other immune-related conditions.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are a rough estimate based on general knowledge as of the knowledge cutoff date and may not reflect the most current research. Moreover, they should not be used as a definitive measure of the gene's association with these statements, and further investigation into the primary research literature is recommended for more accurate scoring."
        ]
    },
    "HS.489254": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "Unfortunately, the gene identifier \"HS.489254\" does not correspond to a standard nomenclature used in genomics databases like NCBI Gene, Ensembl, or HGNC, which typically use either official gene symbols, Entrez Gene IDs, or Ensembl Gene IDs. Due to this, I'm unable to provide a gene name or a summary for this identifier.",
            "",
            "Nevertheless, I can construct a JSON structure for the scoring of the statements you've provided, but please note that without the specific gene information, these scores will be placeholders and should not be considered scientifically accurate or validated. In a real-world application, you'd want to fill in these scores based on evidence from scientific literature, databases, and experimental data.",
            "",
            "Here's the JSON structure with placeholder scores:",
            "",
            "```json",
            "{",
            "  \"gene_name\": \"Unknown\",",
            "  \"brief_summary\": \"No summary available for the gene identifier 'HS.489254'.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 0,",
            "    \"The gene is associated with type II interferon responses\": 0,",
            "    \"The gene is associated with type III interferon responses\": 0,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 0,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 0,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 0",
            "  }",
            "}",
            "```",
            "",
            "Please replace the placeholder scores and other details with accurate information when you have the correct gene identifier or official gene name. You may need to consult current research literature, clinical trial data, and genomics databases to obtain the necessary information to fill in the scores accurately."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"Unknown\",",
            "  \"brief_summary\": \"The gene identifier HS.489254 does not correspond to a standard gene nomenclature, and therefore, no specific information can be provided about this gene. For accurate information, please refer to a valid gene identifier from databases such as NCBI Gene or Ensembl.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 0,",
            "    \"The gene is associated with type II interferon responses\": 0,",
            "    \"The gene is associated with type III interferon responses\": 0,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 0,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 0,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 0",
            "  }",
            "}",
            "```",
            "",
            "Please note that without a valid gene identifier, it is not possible to provide accurate information or evidence scores for the gene HS.489254. If you have a recognized gene identifier, please provide it for more specific information."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "I'm sorry, but HS.489254 doesn't appear to be a standard gene identifier, and as of my last knowledge update in April 2023, I cannot retrieve information about a gene with this identifier. Gene identifiers typically conform to specific formats, such as those provided by the NCBI Gene database or the HUGO Gene Nomenclature Committee (HGNC) for human genes. If you have more context or a different identifier, I could attempt to provide the information you're looking for.",
            "",
            "However, I can provide you with a JSON template for the information and scores you requested. When the correct gene information is available, you can replace the placeholders with the actual data.",
            "",
            "```json",
            "{",
            "  \"gene_name\": \"Placeholder Gene Name\",",
            "  \"brief_summary\": \"Placeholder Summary\",",
            "  \"scores\": {",
            "    \"The gene is associated with type I interferon responses\": 0,",
            "    \"The gene is associated with type II interferon responses\": 0,",
            "    \"The gene is associated with type III interferon responses\": 0,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 0,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 0,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 0,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 0",
            "  }",
            "}",
            "```",
            "",
            "Please provide the correct gene identifier or additional information so that I may assist you further."
        ]
    },
    "TRAFD1": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"TRAFD1\",",
            "  \"brief_summary\": \"TRAFD1, also known as FLN29, is a gene that encodes a protein involved in the negative feedback regulation of the immune response. The protein acts as an adaptor molecule that regulates the TRAF family, which are important components of the signaling pathways of various cytokine receptors. TRAFD1 has been implicated in modulating signaling pathways such as those leading to the production of type I interferons and may play a role in controlling excessive immune responses, thereby maintaining immune homeostasis.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 4,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are a hypothetical estimation based on a general understanding of the gene's function and not on specific, detailed evidence. The actual evidence and scores may differ based on current scientific research and literature. It is recommended to review the latest scientific literature for the most accurate and updated information regarding TRAFD1 and its implications in various biological processes and clinical settings."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "    \"gene_name\": \"TRAFD1\",",
            "    \"Brief_summary\": \"TRAFD1, or TRAF-type zinc finger domain containing 1, is a gene that encodes a protein involved in the modulation of signaling pathways initiated by Toll-like receptors (TLRs) and cytokine receptors. The TRAFD1 protein is known to play a role in the negative regulation of inflammation and innate immune responses, potentially by controlling the levels of signaling adaptors such as TRAF proteins.\"",
            "",
            "    \"statement_scores\": {",
            "        \"The gene is associated with type I interferon responses\": 7,",
            "        \"The gene is associated with type II interferon responses\": 3,",
            "        \"The gene is associated with type III interferon responses\": 2,",
            "        \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "        \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "        \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "        \"The gene is a known drug target\": 0,",
            "        \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "    }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are hypothetical and not based on specific scientific evidence or studies. The actual evidence for such statements may vary, and a thorough review of the latest scientific literature is recommended to obtain accurate information about the role of TRAFD1 in various biological processes and clinical scenarios."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"TRAFD1\",",
            "  \"brief_summary\": \"The TRAFD1 gene, also known as FLN29, encodes a protein that is thought to play a role in modulating the immune response. It is part of the TRAF family and is believed to function in the regulation of signaling pathways that are crucial for immune responses, cell proliferation, and apoptosis. TRAFD1 is known to be involved in the negative regulation of the non-canonical NF-kappaB pathway, which is important for immune system functioning.\",",
            "  \"association_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are hypothetical and for illustrative purposes only. They are not based on specific scientific evidence and should be verified with current research data."
        ]
    },
    "ZC3HAV1": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"ZC3HAV1\",",
            "  \"Brief_summary\": \"ZC3HAV1, also known as Zinc Finger CCCH-Type Containing, Antiviral 1, is a protein-coding gene involved in the innate immune response. It encodes a zinc finger protein that can bind to RNA and is thought to function in the antiviral response by inhibiting the replication of viruses such as HIV-1 by targeting viral RNA for degradation. ZC3HAV1 is also implicated in the regulation of mRNA stability during the immune response.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided here for evidence are estimated based on plausible involvement of the gene in related processes, but actual scores may vary based on the latest research and available evidence. The scores should be validated with the most current scientific literature."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"ZC3HAV1\",",
            "  \"brief_summary\": \"ZC3HAV1 (zinc finger CCCH-type, antiviral 1) is a gene that encodes a protein with a role in antiviral immunity. It is involved in the innate immune response and acts by binding to viral nucleic acids, leading to their degradation and the inhibition of viral replication. The protein is also known as ZAP (zinc-finger antiviral protein). ZC3HAV1 is implicated in the regulation of several cellular processes including apoptosis, cell cycle, and immune responses. It is thought to be important for the host defense against a broad range of viruses.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "The scores provided are subjective estimates based on a general understanding of the gene's role in immune responses, particularly its involvement with type I interferon responses, which is relatively well-documented. The other scores reflect lesser degrees of association or current clinical relevance based on the knowledge available up to the cutoff date. Please note that these scores are not based on specific quantitative data and should be considered as a general guideline rather than definitive evidence."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"ZC3HAV1\",",
            "  \"Brief_summary\": \"ZC3HAV1 (Zinc Finger CCCH-Type Containing, Antiviral 1) is a gene that encodes a protein involved in the innate immune response against viral infections. This protein plays a role in the regulation of the antiviral response and is implicated in controlling the stability and translation of mRNAs for type I interferons and other immune-related molecules. ZC3HAV1 is also known as ZAP (Zinc finger antiviral protein).\",",
            "  \"The gene is associated with type I interferon responses\": 8,",
            "  \"The gene is associated with type II interferon responses\": 3,",
            "  \"The gene is associated with type III interferon responses\": 3,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "}",
            "```"
        ]
    },
    "GBP2": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"GBP2\",",
            "  \"brief_summary\": \"GBP2 (Guanylate Binding Protein 2) is a gene that encodes a member of the guanylate-binding protein (GBP) family within the dynamin superfamily of GTPases. These proteins are known for their ability to hydrolyze GTP to GDP and are induced by interferon-gamma (IFN-\u03b3). GBP2 is involved in various cellular processes including immune response, cell proliferation, and apoptosis. It plays a role in the antimicrobial and antiviral response of cells, often associated with the cellular response to Type II interferon (IFN-\u03b3).\",",
            "  \"statements_score\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 9,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are estimates based on current knowledge and literature available up to the knowledge cutoff date, and actual scores may vary depending on new research and discoveries. The scores reflect the general consensus and evidence available in scientific literature and databases."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"GBP2\",",
            "  \"brief_summary\": \"The GBP2 gene encodes for guanylate binding protein 2, which is a member of the guanylate-binding protein (GBP) family within the large GTPase superfamily. GBP2 is involved in various cellular processes including cell proliferation, cytoskeletal organization, and the immune response to pathogens. It is known to be induced by interferon-gamma and can have antimicrobial activity, particularly against intracellular pathogens. The protein can also participate in the inflammatory response and modulate the activity of other immune cells.\",",
            "  \"scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 9,",
            "    \"The gene is associated with type III interferon responses\": 5,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are somewhat arbitrary and are based on a general understanding of the gene's functions and its role in the immune system. For accurate and up-to-date information, detailed literature reviews and empirical studies should be consulted."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"GBP2\",",
            "  \"brief_summary\": \"GBP2 (Guanylate Binding Protein 2) is a member of the guanylate-binding protein (GBP) family, which is a class of large GTPases that play a role in the cellular response to interferon-gamma (IFN-\u03b3). GBPs are induced by interferons and are known for their antiviral and immunomodulatory functions. GBP2, in particular, has been implicated in various cellular processes including immune responses to pathogens, cell proliferation, and apoptosis. Like other GBPs, GBP2 has been studied for its role in defense against intracellular bacteria, viruses, and its potential involvement in autoimmune diseases.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 6,",
            "    \"The gene is associated with type II interferon responses\": 8,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are based on a general understanding of the gene's involvement in immune responses and are not derived from a specific scientific analysis. These scores should be taken as indicative and would require further validation from up-to-date research and clinical data."
        ]
    },
    "UBE2L6": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"UBE2L6\",",
            "  \"brief_summary\": \"UBE2L6, also known as ubiquitin-conjugating enzyme E2L 6, is a member of the E2 ubiquitin-conjugating enzyme family involved in the ubiquitination pathway, which is a process that tags proteins for degradation by the proteasome. UBE2L6 has been shown to function in the regulation of immune responses, including the ubiquitination and degradation of immune system proteins, and may play a role in the modulation of signal transduction pathways.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are not based on specific scientific data but rather are indicative based on general knowledge about the gene's functions and relationships with immune responses. For accurate and detailed evidence-based assessments, a thorough review of current scientific literature is required."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"UBE2L6\",",
            "  \"brief_summary\": \"UBE2L6, also known as Ubiquitin-Conjugating Enzyme E2L 6, is a member of the E2 ubiquitin-conjugating enzyme family. This gene encodes a protein that is involved in the ubiquitination process, where it cooperates with E1 ubiquitin-activating enzymes and E3 ubiquitin-ligases to transfer ubiquitin to target proteins, thereby marking them for degradation by the proteasome or altering their cellular location or activity. UBE2L6 has been implicated in immune responses, particularly in the context of viral infections and interferon signaling pathways.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "```",
            "",
            "Please note that the evidence scores provided above are not based on specific detailed empirical data but are rather a general estimation based on the current understanding of the gene's function and its role in the immune system. These scores should be taken as an educated guess rather than definitive factual ratings. For precise evidence levels, a thorough review of the latest scientific literature is necessary."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"UBE2L6\",",
            "  \"brief_summary\": \"UBE2L6, also known as Ubiquitin-Conjugating Enzyme E2L 6, is a member of the E2 ubiquitin-conjugating enzyme family involved in the ubiquitination pathway, where it helps to transfer ubiquitin from E1 enzymes to substrate proteins with the assistance of E3 ubiquitin ligases. This action is important for various cellular processes including protein degradation, signal transduction, and immune responses. Due to its role in ubiquitination, UBE2L6 has been implicated in the regulation of immune system functions and responses to interferons.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are not based on an extensive review of the literature. They are an estimation based on the general information available up to early 2023, and the actual evidence might vary as new research is published."
        ]
    },
    "NOD2": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "    \"gene_name\": \"NOD2\",",
            "    \"Brief_summary\": \"NOD2 (nucleotide-binding oligomerization domain-containing protein 2) is an intracellular pattern recognition receptor that plays a critical role in the innate immune system. It recognizes bacterial peptidoglycans, specifically muramyl dipeptide (MDP), and activates NF-kB signaling pathways, leading to the production of inflammatory cytokines. Mutations in the NOD2 gene have been associated with several inflammatory disorders, including Crohn's disease, Blau syndrome, and early-onset sarcoidosis.\",",
            "",
            "    \"Evidence_scores\": {",
            "        \"The gene is associated with type I interferon responses\": 4,",
            "        \"The gene is associated with type II interferon responses\": 6,",
            "        \"The gene is associated with type III interferon responses\": 3,",
            "        \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "        \"The gene or its products are currently being used as a biomarker in clinical settings\": 5,",
            "        \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "        \"The gene is a known drug target\": 5,",
            "        \"The gene is therapeutically relevant for diseases involving the immune system\": 8",
            "    }",
            "}",
            "```",
            "",
            "Please note that the scores given above are not based on specific quantitative data but are rather a general estimation based on current scientific knowledge. For a precise and up-to-date assessment, please refer to the latest peer-reviewed research."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"NOD2\",",
            "  \"brief_summary\": \"NOD2 (nucleotide-binding oligomerization domain-containing protein 2) is an intracellular pattern recognition receptor that plays a critical role in the innate immune system. It is involved in recognizing bacterial components, specifically muramyl dipeptide (MDP) found in peptidoglycan, and is crucial for initiating an immune response. Mutations in the NOD2 gene are associated with several inflammatory disorders, including Crohn's disease, Blau syndrome, and early-onset sarcoidosis.\",",
            "  \"associations\": {",
            "    \"The gene is associated with type I interferon responses\": 3,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 9,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 3,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 8",
            "  }",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"NOD2\",",
            "  \"brief_summary\": \"NOD2 (nucleotide-binding oligomerization domain-containing protein 2) is a protein that is encoded by the NOD2 gene in humans. It is an intracellular pattern recognition receptor that plays a crucial role in the immune system by recognizing bacterial molecules and stimulating an immune reaction. NOD2 is best known for its association with Crohn's disease, an inflammatory bowel disease, but it has also been linked to other inflammatory conditions. Mutations in the NOD2 gene can disrupt its function and lead to an inappropriate immune response.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 4,",
            "    \"The gene is associated with type II interferon responses\": 6,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 4,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided for the evidence are not based on a systematic review and are for illustrative purposes only. The actual evidence supporting the association between NOD2 and the listed statements might vary, and therefore the scores should be validated with current research and expert consultation."
        ]
    },
    "LGALS9": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"LGALS9\",",
            "  \"brief_summary\": \"LGALS9, also known as galectin-9, is a member of the galectin family. It is a beta-galactoside-binding protein that may play a role in cell-cell and cell-matrix interactions. Galectin-9 has been implicated in a variety of biological processes, including immune response regulation, apoptosis, and tumor progression. It interacts with various immune cell receptors and can have both anti-inflammatory and pro-inflammatory effects, depending on the context. LGALS9 has also been studied for its role in viral infections, cancer, and autoimmune diseases.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 6,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided here are generalized estimates based on current knowledge and could vary depending on the context and specific studies. These scores should be regarded as a starting point for further investigation rather than definitive evidence."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"LGALS9\",",
            "  \"Brief_summary\": \"LGALS9, also known as galectin-9, is a member of the galectin family, which are beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectin-9 has various biological functions including regulation of cell adhesion, cell proliferation, apoptosis, and immune response modulation. It interacts with a variety of cell surface molecules and has roles in tumor immunity, T-cell regulation, and inflammatory responses. It can act as a ligand for the T-cell immunoglobulin mucin-3 (TIM-3) receptor, impacting T-cell function and contributing to immune escape mechanisms in cancer. It is expressed in various tissues and can be secreted to function extracellularly.\",",
            "  ",
            "  \"Evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 4,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 5,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are indicative and based on a general understanding of the gene's role in immunology and disease. The actual evidence may vary with emerging research and specific contexts, so these scores should be corroborated with up-to-date literature and clinical findings."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"LGALS9\",",
            "  \"Brief_summary\": \"LGALS9, or galectin-9, is a member of the galectin family, which are beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectin-9 plays a role in various biological processes including immune response regulation, apoptosis, and cell adhesion. It can influence T-cell immune responses and may also have roles in tumor progression and metastasis.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 5,",
            "    \"The gene is associated with type II interferon responses\": 7,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that these scores are provided based on a general understanding of the gene's role in immunology and may not reflect the most current research data. The scores should be considered as indicative rather than definitive and may differ depending on the context of each statement."
        ]
    }
}